why choose us

First received: May 31, 2023

Clinical Trial: A Phase 3 Study of VSA001 in Chinese Adults With Familial Chylomicronemia Syndrome

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Familial Chylomicronemia Syndrome

Study Type: INTERVENTIONAL


Official Title: Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Chinese Adults With Familial Chylomicronemia Syndrome

Brief Summary: This is a randomized, double-blinded, placebo controlled, two periods phase 3 clinical study.The primary objective of the study is to evaluate the efficacy and safety of VSA001 injection in Chinese adults with familial chylomicronemia syndrome (FCS).A total of approximately 30 participants will be enrolled in the study.

Read more